Brief: Senores Pharmaceuticals Says Havix Completes USFDA Inspection With 3 Observations
28/07/2025 11:35
July 28 (Reuters) - Senores Pharmaceuticals Ltd SENO.NS: SENORES PHARMACEUTICALS LTD - HAVIX COMPLETES USFDA INSPECTION WITH 3 OBSERVATIONS SENORES PHARMACEUTICALS LTD - HAVIX TO RESPOND TO MINOR OBSERVATIONS WITHIN 15 DAYS Source text: ID:nBSE62ZHyy Further company coverage: SENO.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees